Analysis of the SELECT trialassessing the cardiovascular impact of the diabetes and anti-obesity medication semaglutide (Wegovy, Novo Nordisk)has found that the use of the drug significantly reduced the risk of major adverse cardiovascular events (MACE) regardless of the amount of weight individuals lost
Were your second set of eyes
Furthermore, a study in JAMA found that patients taking oral Semaglutide GLP-1 lost a similar amount of weight as those on the injectable form, suggesting oral Semaglutide GLP-1 could be a more convenient option for some patients
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats
This guide gives you 15 tested recipes built specifically for people on GLP-1 medications, plus the science behind every ingredient choice, troubleshooting for common problems, and a weekly plan you can follow starting today
Its important to document when symptoms begin and how they progress